Carlsmed Sues DeGen Medical for Infringement of Eight Patents

Regulation
โดย GlobeNewswire·US·Read original
Summary · why it matters

Carlsmed, Inc. has filed a patent infringement lawsuit against DeGen Medical, Inc. in the United States District Court for the District of South Carolina Florence Division. The complaint asserts that DeGen is infringing eight of Carlsmed's patents relating to its implants, methods and systems, and Carlsmed is seeking injunctive relief and damages for infringement. Mike Cordonnier, Chairman and CEO of Carlsmed, said the company is committed to protecting the intellectual property that supports its patient-centric innovation. Carlsmed is a medical technology company pioneering AI-enabled personalized spine surgery solutions.

Impact on stocks 2

Artificial Intelligence▲ · 1 stocks
Carlsmed, Inc.
CARL
▲ PositiveRegulationrelevance

Carlsmed filed a patent infringement lawsuit against DeGen Medical seeking injunctive relief and damages to protect its IP.

Aging Population▲ · 1 stocks

Off-coverage companies 1

DeGen Medical, Inc.Private▼ Negative
Regulationrelevance

DeGen Medical is accused of infringing eight Carlsmed patents and faces injunctive relief and damages.

© 2026 MarketDXNews